Philips breaks new ground in Point-of-Care Ultrasound with launch of Flash 5100 POC
Royal Philips announced the global launch of the Flash Ultrasound System 5100 POC โ a breakthrough point-of-care (POC) ultrasound system engineered for the fast-moving... Read more.
Applications open for the Third NMSS Research Grant Cycle (2025-2026)
The National Multiple Sclerosis Society (NMSS) in the UAE has announced the launch of its third research grant cycle for 2025-2026, under the theme Advancing MS... Read more.
WHO Honors HMCโs Tobacco Control Center with 2025 World No Tobacco Day Award
The World Health Organization (WHO) has recognized Hamad Medical Corporationโs (HMC) Tobacco Control Center with the 2025 World No Tobacco Day Award. The award... Read more.
Revolutionizing Pain Management with Exosomes | Dr. Ernesto Delgado Cidranes at AIDA 2025
Dr. Ernesto, an anesthesiology expert in pain management, discussed the revolutionary role of exosomes in treating pain, particularly after aesthetic procedures.... Read more.
Siemens Healthineers Announces Theranostics Research Collaboration With MGH
Siemens Healthineers Molecular Imaging has entered into a research collaboration with leading healthcare institution Massachusetts General Hospital (MGH) to support... Read more.
MSF Warns of Gazaโs Spiraling Medical and Humanitarian Collapse Amid Fuel and Aid Blockade
Mรฉdecins Sans Frontiรจres (MSF) has raised grave concerns over the rapidly deteriorating humanitarian situation in Gaza, as Israeli authorities continue to impose... Read more.
Mobile clinics enhance access to health care services in Niger
In Niger, West Africaโs largest country by land surface, access to health care services is a major challenge. Just one in two people has access to health services.... Read more.
Dubai Hosts 5th International Neuroscience Summit for Middle East, Africa, and Russia Region
The International Neurology Conference for the Middle East, Africa and Russia kicked off in Dubai, in cooperation with AbbVie, the global biopharmaceutical research... Read more.
Yeztugo by Gilead Gets FDA OK, Promises Easier HIV Prevention
Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugoยฎ (lenacapavir)โthe companyโs injectable HIV-1 capsid inhibitorโas... Read more.
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, announced a definitive... Read more.
